Top compounds associated with response to DHRS7C


Feature Type Standardized
Nominal ANOVA
mRNA neratinib CTRPv2 pan-cancer AAC -0.023 0.5
mRNA A-804598 CTRPv2 pan-cancer AAC 0.03 0.5
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA momelotinib CTRPv2 pan-cancer AAC -0.022 0.5
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.035 0.5
mRNA hyperforin CTRPv2 pan-cancer AAC -0.025 0.5
mRNA MS-275 GDSC1000 pan-cancer AAC -0.035 0.5
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.5
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC 0.025 0.5
Download CSV